tubulin beta-8 chain (isoform 1), a potential drug target and biomarker for neurodegenerative diseases

Target Name: TUBB8

NCBI ID: G347688

TUBB8

tubulin beta-8 chain (isoform 1), a potential drug target and biomarker for neurodegenerative diseases

Abstract:
Tubulin beta-8 chain (isoform 1) is a protein that plays a crucial role in the structure and function of microtubules, which are essential for the transport and organization of various cellular processes. The dysfunction of tubulin beta-8 chain has been implicated in a variety of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases. This article discusses the current understanding of tubulin beta-8 chain and its potential as a drug target and biomarker for neurodegenerative diseases.

Introduction:
Tubulin beta-8 chain (isoform 1) is a protein that is synthesized from a single amino acid residue and is composed of four structural subunits. It plays a critical role in the structure and function of microtubules, which are composed of a protein filament called tubulin and several other protein subunits. The microtubules are responsible for the transport and organization of various cellular processes, including intracellular transport, cell division, and cell signaling.

Dysfunction of tubulin beta-8 chain in neurodegenerative diseases:
The dysfunction of tubulin beta-8 chain has been implicated in a variety of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases. These conditions are characterized by the progressive loss of brain cells and the formation of aggregates of misfolded proteins, including tubulin beta-8 chain. The misfolding of tubulin beta-8 chain is thought to occur due to a variety of factors, including genetic and environmental factors.

Tubulin beta-8 chain as a drug target:
Tubulin beta-8 chain has been identified as a potential drug target for neurodegenerative diseases due to its involvement in the structure and function of microtubules. Several studies have shown that inhibiting tubulin beta-8 chain can lead to the regression of neurodegenerative symptoms, including the loss of cognitive and motor function. Additionally, preclinical studies have shown that tubulin beta-8 chain inhibitors can protect against neurodegenerate diseases by modulating the expression of genes involved in neurodegeneration.

Tubulin beta-8 chain as a biomarker:
Tubulin beta-8 chain has also been identified as a potential biomarker for neurodegenerative diseases due to its stability and expression in brain tissue. Several studies have shown that tubulin beta-8 chain is expressed in brain tissue and is highly stable under various conditions, including normal brain function and neurodegenerative disease. Additionally, the levels of tubulin beta-8 chain have been shown to be associated with the severity of neurodegenerative symptoms, suggesting that it may serve as a sensitive marker for disease progression.

Conclusion:
Tubulin beta-8 chain (isoform 1) is a protein that plays a crucial role in the structure and function of microtubules and has been implicated in a variety of neurodegenerative diseases. Its dysfunction has been implicated in the development of Alzheimer's, Parkinson's, and Huntington's diseases. As a result, tubulin beta-8 chain has emerged as a potential drug target and biomarker for these conditions. Further research is needed to fully understand its role in neurodegenerative diseases and to develop effective treatments.

Protein Name: Tubulin Beta 8 Class VIII

Functions: Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. TUBB8 has a key role in meiotic spindle assembly and oocyte maturation (PubMed:26789871, PubMed:34509376)

The "TUBB8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUBB8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets